Bareilly Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 10-12-2024
- Satisfied Charges ₹ 5.00 M
as on 10-12-2024
About Bareilly Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arun Agarwal, Sanjeev Agarwal, Naveen Agarwal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232UP1998PTC023244
- Company No.
023244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 1998
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bareilly Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Agarwal  | Whole-Time Director | 18-Mar-1998 | Current |
| Sanjeev Agarwal | Whole-Time Director | 18-Mar-1998 | Current |
| Naveen Agarwal | Whole-Time Director | 18-Mar-1998 | Current |
| Rajeev Agarwal | Whole-Time Director | 18-Jul-2001 | Current |
| Vinay Agarwal | Whole-Time Director | 18-Jul-2001 | Current |
Financial Performance of Bareilly Pharmaceuticals.
Bareilly Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bareilly Pharmaceuticals?
In 2017, Bareilly Pharmaceuticals had a promoter holding of 96.20% and a public holding of 3.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Dec 2022 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 17 Feb 2006 | ₹5.00 M | Satisfied |
How Many Employees Work at Bareilly Pharmaceuticals?
Unlock and access historical data on people associated with Bareilly Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bareilly Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bareilly Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
